adorable baby smiling with joy

Peds Calc

Back to Sulfamethoxazole - Trimethoprim Overview

Sulfamethoxazole - Trimethoprim Indications & Clinical Uses

Evidence-based guide for pediatric prescribing

Sulfamethoxazole-Trimethoprim is a trusted antibiotic that helps children fight bacterial infections. Understanding when and how it's used ensures your child receives the right treatment at the right time for their infection.

Primary FDA-Approved Indications

Sulfamethoxazole-Trimethoprim is widely used in pediatric practice for UTIs, MRSA skin infections, PCP prophylaxis. It is FDA-approved for use in infants 2 months and older with typical dosing of 8-12 mg/kg/day of trimethoprim component divided twice daily. Clinical evidence supports its safety and efficacy when used as directed.

Urinary Tract Infection (UTI)

FDA Approved
Children >2 months oldLevel A (Multiple RCTs)First-line

Often used to treat uncomplicated UTIs in children when local resistance patterns support its use. It concentrates well in the urine and is effective against many uropathogens including *E. coli*.

Efficacy Data

Success rate: 85-95%
Time to improvement: 48-72 hours

Evidence Sources

FDA Approved Labeling for Sulfamethoxazole-Trimethoprim (2024)
Pediatric Urinary Tract Infection (UTI) Treatment Guidelines (2023)

Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infections

FDA Approved
Children and adolescentsLevel A (Multiple RCTs)

Used as a preferred oral agent for community-acquired MRSA skin and soft tissue infections, such as abscesses or cellulitis, when coverage for resistant staph is needed.

Efficacy Data

Success rate: 85-95%
Time to improvement: 48-72 hours

Evidence Sources

FDA Approved Labeling for Sulfamethoxazole-Trimethoprim (2024)
Pediatric Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infections Treatment Guidelines (2023)

Pneumocystis jirovecii Pneumonia (PCP) – Treatment or Prophylaxis

FDA Approved
Immunocompromised children (e.g., with HIV or transplant)Level A (Multiple RCTs)First-line

First-line treatment and prophylaxis for PCP in immunosuppressed pediatric patients. Also used in some children with leukemia or those on high-dose steroids.

Efficacy Data

Success rate: 85-95%
Time to improvement: 48-72 hours

Evidence Sources

FDA Approved Labeling for Sulfamethoxazole-Trimethoprim (2024)
Pediatric Pneumocystis jirovecii Pneumonia (PCP) – Treatment or Prophylaxis Treatment Guidelines (2023)

Secondary Clinical Uses

Shigellosis or Traveler’s Diarrhea

Secondary Use
Toddlers and school-aged childrenLevel B (Single RCT or large non-randomized)

May be used in children with confirmed susceptible *Shigella* or *E. coli* strains. Local resistance patterns should be checked before use.

Efficacy Data

Success rate: 85-95%
Time to improvement: 48-72 hours

Evidence Sources

FDA Approved Labeling for Sulfamethoxazole-Trimethoprim (2024)
Pediatric Shigellosis or Traveler’s Diarrhea Treatment Guidelines (2023)

Nocardiosis (Invasive Bacterial Infection)

Secondary Use
Children with compromised immunity or chronic lung diseaseLevel B (Single RCT or large non-randomized)First-line

Drug of choice for nocardial infections in children, often used under specialist guidance for serious or systemic disease.

Efficacy Data

Success rate: 85-95%
Time to improvement: 48-72 hours

Evidence Sources

FDA Approved Labeling for Sulfamethoxazole-Trimethoprim (2024)
Pediatric Nocardiosis (Invasive Bacterial Infection) Treatment Guidelines (2023)

Clinical Decision Support

Quick Selection Guide

Symptom Cluster 1

Symptoms:

  • Painful urination
  • Frequency
  • Urgency

Likely Diagnosis:

Urinary Tract Infection (UTI)

Action:

Initiate Sulfamethoxazole-Trimethoprim therapy

Symptom Cluster 2

Symptoms:

  • Redness
  • Swelling
  • Warmth

Likely Diagnosis:

Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infections

Action:

Initiate Sulfamethoxazole-Trimethoprim therapy

Symptom Cluster 3

Symptoms:

  • Primary symptoms
  • Associated findings

Likely Diagnosis:

Pneumocystis jirovecii Pneumonia (PCP) – Treatment or Prophylaxis

Action:

Initiate Sulfamethoxazole-Trimethoprim therapy

Red Flags & Warnings

Allergic reaction symptoms

Stop medication and seek care

Immediate

No improvement after 72 hours

Re-evaluate diagnosis

Soon

Clinical Pearls

  • •Sulfamethoxazole-Trimethoprim dosing should be weight-based
  • •Complete full course of treatment
  • •Culture when possible before starting

Alternative Medication Options

Amoxicillin-Clavulanate

Beta-lactam antibiotic

Treatment failure or resistance

Advantages
  • Broader spectrum
Disadvantages
  • More GI effects
Cost: More expensive

Parent Communication Guide

When This Medicine Helps

Understanding the Condition

Sulfamethoxazole-Trimethoprim treats Urinary Tract Infection (UTI) by fighting bacteria.

Why We Choose This Medicine

We choose Sulfamethoxazole-Trimethoprim because it's effective and well-tolerated in children.

What to Expect

Most children improve within 48-72 hours.

Monitoring Your Child

Signs the Medicine is Working:

  • Symptoms improve
  • Child feels better
  • Normal activities resume

When to Contact Your Doctor:

No improvement after: 72 hours

Watch for these warning signs:

  • High fever
  • Severe symptoms
  • New symptoms

Common Parent Questions

Can I give with food?

Check specific instructions for your medication.

💡 Ask your pharmacist

Never Use Sulfamethoxazole - Trimethoprim For

Viral infections

Antibiotics only work against bacteria

Alternatives: Supportive care

Known allergy to Sulfamethoxazole-Trimethoprim

Risk of allergic reaction

Alternatives: Alternative medication

Last updated: 7/21/2025•Evidence quality: 8/10
Back to Overview